Deep-learning-based cardiovascular risk stratification using coronary artery calcium scores predicted from retinal photographs

Tyler Hyungtaek Rim(Yonsei University), Chan Joo Lee(Yonsei University), Yih Chung Tham(Singapore National Eye Center), Ning Cheung(Singapore National Eye Center), Marco Yu(Singapore National Eye Center), Geunyoung Lee, Youngnam Kim(Yonsei University), Daniel Shu Wei Ting(Singapore National Eye Center), Crystal Chun Yuen Chong(Singapore National Eye Center), Yoon Seong Choi(Yonsei University), Tae Keun Yoo(Yonsei University), Ik Hee Ryu(Nune Eye Hospital), Su Jung Baik(Yonsei University), Young Ah Kim(Yonsei University), Sung Kyu Kim(Severance Hospital), Sang‐Hak Lee(Yonsei University), Byoung Kwon Lee(Yonsei University), Seok‐Min Kang(Yonsei University), Edmund Yick Mun Wong(Singapore National Eye Center), Hyeon Chang Kim(Yonsei University), Sung Soo Kim(Yonsei University), Sungha Park(Yonsei University), Ching‐Yu Cheng(Singapore National Eye Center), Tien Yin Wong(Singapore National Eye Center)
The Lancet Digital Health
April 21, 2021
Cited by 210Open Access
Full Text

Abstract

BACKGROUND: Coronary artery calcium (CAC) score is a clinically validated marker of cardiovascular disease risk. We developed and validated a novel cardiovascular risk stratification system based on deep-learning-predicted CAC from retinal photographs. METHODS: We used 216 152 retinal photographs from five datasets from South Korea, Singapore, and the UK to train and validate the algorithms. First, using one dataset from a South Korean health-screening centre, we trained a deep-learning algorithm to predict the probability of the presence of CAC (ie, deep-learning retinal CAC score, RetiCAC). We stratified RetiCAC scores into tertiles and used Cox proportional hazards models to evaluate the ability of RetiCAC to predict cardiovascular events based on external test sets from South Korea, Singapore, and the UK Biobank. We evaluated the incremental values of RetiCAC when added to the Pooled Cohort Equation (PCE) for participants in the UK Biobank. FINDINGS: RetiCAC outperformed all single clinical parameter models in predicting the presence of CAC (area under the receiver operating characteristic curve of 0·742, 95% CI 0·732-0·753). Among the 527 participants in the South Korean clinical cohort, 33 (6·3%) had cardiovascular events during the 5-year follow-up. When compared with the current CAC risk stratification (0, >0-100, and >100), the three-strata RetiCAC showed comparable prognostic performance with a concordance index of 0·71. In the Singapore population-based cohort (n=8551), 310 (3·6%) participants had fatal cardiovascular events over 10 years, and the three-strata RetiCAC was significantly associated with increased risk of fatal cardiovascular events (hazard ratio [HR] trend 1·33, 95% CI 1·04-1·71). In the UK Biobank (n=47 679), 337 (0·7%) participants had fatal cardiovascular events over 10 years. When added to the PCE, the three-strata RetiCAC improved cardiovascular risk stratification in the intermediate-risk group (HR trend 1·28, 95% CI 1·07-1·54) and borderline-risk group (1·62, 1·04-2·54), and the continuous net reclassification index was 0·261 (95% CI 0·124-0·364). INTERPRETATION: A deep learning and retinal photograph-derived CAC score is comparable to CT scan-measured CAC in predicting cardiovascular events, and improves on current risk stratification approaches for cardiovascular disease events. These data suggest retinal photograph-based deep learning has the potential to be used as an alternative measure of CAC, especially in low-resource settings. FUNDING: Yonsei University College of Medicine; Ministry of Health and Welfare, Korea Institute for Advancement of Technology, South Korea; Agency for Science, Technology, and Research; and National Medical Research Council, Singapore.


Related Papers

No related papers found

Powered by citation graph analysis